We concluded that SRRM2 is present on the surface of cancer-derived EVs and, hence, constitutes a marker for detection of cancer-derived EVs and is, thus, a potential diagnostic and prognostic circulating biomarker. This evidence concerns the gene SRRM2 and cancer.